Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.56 |
| ▸ | PLA2G2A | P14555 | 7/20 | 0.55 |
| ▸ | PLA2G10 | O15496 | 6/20 | 0.55 |
| ▸ | HNF4A | P41235 | 2/20 | 0.54 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.52 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.51 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.51 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.49 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.49 |
| ▸ | PLA2G12B | Q9BX93 | 1/20 | 0.49 |
| ▸ | PLA2G12A | Q9BZM1 | 1/20 | 0.49 |
| ▸ | PLA2G2F | Q9BZM2 | 1/20 | 0.49 |
| ▸ | PLA2G3 | Q9NZ20 | 1/20 | 0.49 |
| ▸ | PLA2G2E | Q9NZK7 | 1/20 | 0.49 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22071096 | 0.87 | ACMSD (0.60) | ACMSDPTPN1HNF4APTPN2PTPN6 | |
| SCHEMBL18414391 | 0.85 | BCL2 (0.58) | ACMSDHNF4ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19237016 | 0.85 | CFD (0.50) | ACMSDHNF4ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9341892 | 0.85 | LTB4R2 (0.49) | ACMSDPTPN1HNF4ANPC1RAB9A | |
| Hydrochloric Acid SCHEMBL20593581 | 0.84 | CFD (0.49) | ACMSDHNF4ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL689031 | 0.84 | HNF4A (0.62) | ACMSDPTPN1HNF4ANPC1RAB9A | |
| SCHEMBL7252300 | 0.80 | ACMSD (0.59) | ACMSDPTPN1HNF4ANPC1RAB9A | |
| SCHEMBL7407371 | 0.80 | HNF4A (0.73) | PTPN1HNF4ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL31688936 | 0.79 | MAPK1 (0.64) | — | |
| SCHEMBL27362497 | 0.79 | CYP4F2 (0.50) | RAB9ACYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4309421-A | Stabilized parenterally administrable solutions | A. NATTERMANN & CIE. GMBH (DE) | 1982-01-05 | — | — | US | claimed |
| EP-2065047-A1 | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein | Board of Regents, The University of Texas System (US) | 2009-06-03 | — | — | EP | disclosed |
| EP-1214940-B1 | Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein | UNIV TEXAS (US) | 2009-03-11 | — | — | EP | disclosed |
| EP-1214940-A1 | Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-06-19 | — | — | EP | disclosed |
| EP-0805684-B1 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | UNIV TEXAS (US) | 2002-06-12 | — | — | EP | disclosed |
| US-5955451-A | NONSTEROID ANTIINFLAMMATORY AGENTS COMPLEXED WITH ZWITTERIONS OR PHOSPHOLIPIDS FOR NONIRRITATION OF GASTROINTESTINAL SYSTEMS AND ANTIPYRETICS | THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS | 1999-09-21 | — | — | US | disclosed |
| WO-1998013073-A9 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | — | 1998-08-06 | — | — | WO | disclosed |
| EP-0805684-A4 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | UNIV TEXAS (US) | 1998-08-05 | — | — | EP | disclosed |
| US-5763422-A | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-06-09 | — | — | US | disclosed |
| WO-1998013073-A1 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-04-02 | — | — | WO | disclosed |
| EP-0805684-A2 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022780-A1 | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDS AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 1996-08-01 | — | — | WO | disclosed |
| US-4528193-A | Inflammation-preventing pharmaceutical composition of oral administration | A. NATTERMAN & CIE. GMBH (DE) | 1985-07-09 | — | — | US | disclosed |
| US-4421747-A | PHOSPHOLIPID AND DERIVATIVE OF PHENYLACETIC OR PHENYLPROPIONIC ACID | A. NATTERMANN & CIE. GMBH (DE) | 1983-12-20 | — | — | US | disclosed |
| US-4378354-A | CONSISTING OF A PHOSPHOLIPID AND SALICYLIC ACID OR DERIVATIVE | A. NATTERMANN & CIE. GMBH (DE) | 1983-03-29 | — | — | US | disclosed |
| US-4369182-A | Inflammation-preventing pharmaceutical composition of oral administration | A. NATTERMANN & CIE GMBH (DE) | 1983-01-18 | — | — | US | disclosed |
| US-4332795-A | INDOLE COMPOUND AND PHOSPHOLIPID | A. NATTERMANN & CIE. GMBH (DE) | 1982-06-01 | — | — | US | disclosed |
| US-4309421-A | Stabilized parenterally administrable solutions | A. NATTERMANN & CIE. GMBH (DE) | 1982-01-05 | — | — | US | disclosed |